S7 E9: Best DOAC for VTE; Muscle loss with GLP1s; CDSSs - why don't we use them?

Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode, we have three new pieces of research that affect us in general practice. First: What interim anti-coagulation would you give your patient with suspected VTE? One common option has 5 times the rate of major bleeding. Second: How much muscle mass do people lose with weight loss on GLP1s? Is this different from lifestyle-based interventions, and is there anything patients can do about it? Third: Why don't we use clinical decision support tools for cancer? This research looks at the barriers and then I over-share my own thoughts on the subject... References NEJM Apixaban or rivaroxaban bleeding risk with acute VTE Diabetes, Obesity & Metabolism Lean mass loss with incretin therapies vs lifestyle interventions BJGP: Why don't we use clinical decision tools www.nbmedical.com/podcast